| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,396 |
7,874 |
$584K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,504 |
10,740 |
$528K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,781 |
4,279 |
$283K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,717 |
4,246 |
$268K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
8,166 |
7,023 |
$101K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,520 |
1,400 |
$92K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,794 |
8,607 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,654 |
2,291 |
$67K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,034 |
4,581 |
$66K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,188 |
728 |
$55K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,538 |
1,017 |
$31K |
| 92551 |
|
3,233 |
2,904 |
$22K |
| 99188 |
|
1,144 |
892 |
$20K |
| 90474 |
|
2,221 |
2,087 |
$19K |
| 96161 |
|
3,804 |
3,109 |
$18K |
| 87634 |
|
449 |
294 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
272 |
215 |
$14K |
| 99381 |
|
245 |
187 |
$13K |
| 97803 |
|
5,003 |
3,762 |
$8K |
| 99173 |
|
5,098 |
4,266 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
227 |
153 |
$7K |
| 99051 |
|
421 |
353 |
$6K |
| 96160 |
|
10,141 |
7,780 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
253 |
138 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
92 |
56 |
$4K |
| 96127 |
|
3,060 |
2,451 |
$3K |
| 92552 |
|
202 |
179 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
232 |
193 |
$2K |
| 99382 |
|
53 |
26 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
172 |
70 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
106 |
102 |
$1K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
14 |
13 |
$880.11 |
| 99383 |
|
14 |
12 |
$744.16 |
| 99177 |
|
813 |
567 |
$504.58 |
| 87807 |
|
49 |
35 |
$418.15 |
| 99462 |
|
15 |
13 |
$299.76 |
| 90670 |
|
2,328 |
2,026 |
$75.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
222 |
94 |
$69.65 |
| 90698 |
|
1,160 |
942 |
$43.75 |
| 90680 |
|
2,562 |
2,277 |
$37.50 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
13 |
$34.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
12 |
$18.75 |
| 90461 |
|
58 |
42 |
$7.50 |
| 90633 |
|
1,518 |
1,277 |
$0.04 |
| 90671 |
|
1,439 |
1,190 |
$0.02 |
| 90697 |
|
2,047 |
1,843 |
$0.00 |
| 90686 |
|
1,835 |
1,597 |
$0.00 |
| 90716 |
|
198 |
185 |
$0.00 |
| 90744 |
|
387 |
329 |
$0.00 |
| 90656 |
|
191 |
164 |
$0.00 |
| 90696 |
|
73 |
65 |
$0.00 |
| 90707 |
|
198 |
186 |
$0.00 |
| 90672 |
|
12 |
12 |
$0.00 |
| 90710 |
|
62 |
54 |
$0.00 |